Evidence map›Paper›PMID 38368935›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2024

Differential effects of

Swati Mishra, Suman Jayadev, Jessica E Young

Open access · hybridAbstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 7 citations in OpenAlex.

  1. LR11/SorLA and its role in cardiovascular disease.International journal of cardiology. Heart & vasculature · 2026
    Review
  2. Article
  3. Article
  4. Gene-Modulated Network Diffusion for Improved Modeling of Amyloid-bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Article
  7. Familial Alzheimer's disease mutation identifies novel role of SORLA in release of neurotrophic exosomes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Article
  10. Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Swati MishraDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA.
Suman JayadevDeparment of Neurology, University of Washington, Seattle, WA 98109, USA.
Jessica E YoungDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0003-2106-0339
University of Washington · US

Funding

Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.R01AG062148 · NIA · UNIVERSITY OF WASHINGTON · PI YOUNG, JESSICA ELAINE · 2018 to 2022
$3.2M
Role of HDAC2 as a modulator of aging and Alzheimer's disease phenotypes in stem-cell derived neuronsK01AG059841 · NIA · UNIVERSITY OF WASHINGTON · PI YOUNG, JESSICA ELAINE · 2019 to 2023
$612k
NIA NIH HHS K01 AG059841NIA NIH HHS R01 AG062148
6 · The paper itself

Abstract

The endosomal gene

Indexed as

Alzheimer DiseaseBrainHumansLDL-Receptor Related ProteinsLysosomesMembrane Transport ProteinsMicrogliaNeuronsLDL-Receptor Related ProteinsMembrane Transport ProteinsSORL1 protein, humanAlzheimer's diseaseendosomal traffickingmicroglianeuronsSORL1

Identifiers

PMID38368935
PMCPMC10874699
OpenAlexW4391921653

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.